Peganum harmala leaf extract mediated green synthesised polyvinyl alcohol zinc oxide beta cyclodextrin nanocomposite for anticancer and antimicrobial applications Authors: Abdulrahman Alasmari, Chellasamy Panneerselvam Published: 2026 ABSTRACT The present study describes the eco-friendly synthesis and multifunctional investigation of a Peganum harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite. The synthesised nanocomposite was characterised by UV–Vis, FTIR, and XRD analyses, which confirmed the formation of crystalline ZnO NPs within the PVA/β-CD network. The UV–Vis absorption peak at 354.34 nm indicated quantum confinement effects, while FTIR spectra verified Zn–O bond formation and strong intermolecular interactions among ZnO, β-CD, and PVA. XRD patterns demonstrated the hexagonal wurtzite structure of ZnO with nanoscale crystallinity. Morphological analysis by FE-SEM and HR-TEM revealed uniformly distributed quasi-spherical NPs (15–25 nm) embedded within the polymeric network. Elemental mapping further confirmed the presence of Zn, C, and O as major constituents. Additionally, DLS and zeta potential analyses indicated excellent colloidal stability (–33.62 mV) and a narrow nanosized distribution (299.4 nm). Biological evaluation demonstrated potent, selective anticancer activity of the nanocomposite against MDA-MB-231 triple-negative breast cancer cells, with time-dependent IC₅₀ values of 24.45, 20.83, and 12.74 µg/mL at 24, 48, and 72 h, respectively. In contrast, it exhibited minimal cytotoxicity toward normal HMECs. Mechanistic studies revealed enhanced ROS generation, depletion of antioxidant defences, mitochondrial dysfunction, and induction of apoptosis via the intrinsic pathway, as supported by morphological staining and apoptotic gene modulation. Moreover, the nanocomposite exhibited broad-spectrum antibacterial and antifungal activities, particularly against S. aureus, S. pneumoniae, and Candida species. These results highlight the P. harmala–mediated PVA/ZnO@β-CD nanocomposite as a promising, green-engineered nanotherapeutic candidate with potent anticancer and antimicrobial potential.Supplementary InformationThe online version contains supplementary material available at 10.1186/s11671-026-04593-8. Introduction The growing global concern for environmental sustainability has catalysed significant advancements in materials science, particularly in the development of “green” materials. Green nanocomposites, which integrate biodegradable polymers and eco-friendly nanoparticles, represent a promising frontier with diverse applications in the biomedical field [1, 2]. These materials offer numerous advantages, including biocompatibility, biodegradability, and reduced toxicity, making them ideal candidates for drug delivery, tissue engineering, and diagnostics [3, 4]. The shift toward green synthesis methods for nanoparticles further enhances their appeal, as these methods minimise hazardous chemicals and energy consumption during production and often utilise plant extracts [5, 6]. Among green nanocomposite systems, those incorporating polyvinyl alcohol and zinc oxide nanoparticles have attracted considerable attention owing to their unique properties and versatile applications [7]. PVA is a water-soluble, non-toxic, biocompatible, and biodegradable synthetic polymer with excellent film-forming capabilities and high mechanical strength [8]. These characteristics make it a suitable matrix for various biomedical applications, including drug delivery systems, where it can enhance drug stability and controlled release [9]. Zinc oxide nanoparticles are well-known for their broad-spectrum antimicrobial activity, photocatalytic properties, and diverse biological effects [10]. Specifically, ZnO NPs have demonstrated significant anticancer potential, primarily by generating reactive oxygen species and inducing oxidative stress, thereby inducing programmed cell death in cancer cells [11]. ZnO’s ability to act as a photocatalyst, generating ROS upon light exposure, further contributes to its efficacy in various biomedical contexts [12]. Green synthesis routes, often employing plant extracts, are increasingly utilised to produce nanoparticles, thereby aligning with principles of sustainability and reducing environmental impact [13]. The combination of PVA and ZnO NPs results in nanocomposites with enhanced physical, chemical, and biological properties. For instance, PVA/ZnO nanocomposites exhibit improved thermal stability and significant antibacterial activity [14]. Furthermore, the interaction between ZnO and the functional groups of PVA polymers has been confirmed, indicating a successful hybrid nanocomposite formation with potential for advanced applications [7]. Peganum harmala, a perennial herbaceous plant, has traditionally been recognised for its diverse medicinal properties [15]. Phytochemical studies have revealed the bioactive compounds, including beta-carboline alkaloids such as harmine, harmaline, and harmalol, as well as quinazoline alkaloids [16]. These compounds contribute to its therapeutic effects, which include significant anticancer, antimicrobial, and anti-inflammatory activities [17]. Research indicates that P. harmala extracts and their isolated compounds exhibit considerable anticancer activity against various human cancer cell lines, including breast cancer, by inhibiting proliferation and inducing apoptosis [18]. The plant’s ability to induce cell death and inhibit cancer cell growth underscores its potential as a source of novel cytotoxic agents. Encapsulation techniques are crucial for enhancing the stability, bioavailability, and targeted delivery of natural bioactive compounds, such as those found in P. harmala extracts, which often exhibit poor solubility and chemical instability [19]. These methods protect the active ingredients from degradation, facilitate controlled release, and can reduce potential toxicity, thereby improving overall therapeutic efficacy. Breast cancer remains a formidable global health challenge, affecting millions of women annually and often associated with poor prognosis due to drug resistance and limited effective therapies [20]. The urgent need for new therapeutic strategies has led researchers to explore natural products and nanotechnology as promising avenues [21]. Natural products offer a rich source of anticancer agents, but their clinical translation is often hindered by poor stability and low bioavailability [20]. Nanotechnology provides innovative solutions to overcome these limitations by enabling targeted drug delivery, improving solubility, and enhancing therapeutic efficacy. Nanomaterials can selectively target tumour cells, minimise damage to healthy tissues, and potentially overcome drug resistance mechanisms [22]. Beta-cyclodextrins (β-CDs), for instance, are cyclic oligosaccharides that are widely used to form inclusion complexes with hydrophobic molecules, thereby improving the solubility and stability of encapsulated drugs [23, 24]. Their use in nanocomposites further enhances targeted drug delivery and offers potential in cancer therapy [25, 26]. Combinations of β-CD with polymers such as PVA and nanoparticles such as ZnO have been explored to develop multifunctional systems for drug delivery [27]. This study aims to formulate and analyse an eco-friendly P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite and to evaluate its multifunctional anticancer and antimicrobial activities. The study emphasises its potential as a green-engineered nanotherapeutic with strong biocompatibility and efficacy against breast cancer and pathogenic microbes. Materials and methods Chemicals and reagents Zinc nitrate hexahydrate, PVA, β-CD, MTT (3-(4,5- and often utilise-yl)-2,5-diphenyltetrazolium bromide), AO (acridine orange), EtBr (ethidium bromide), DCFDA (2′,7′-dichlorofluorescein diacetate), and DAPI (4′,6-diamidino-2-phenylindole) were purchased from Sigma-Aldrich (USA). All compounds were analytical grade and utilised without further purification. Hi-Media provided cell culture reagents such as DMEM (Dulbecco’s Modified Eagle Medium), FBS (fetal bovine serum), and penicillin and streptomycin (antibiotics). All preparations were carried out using deionised water. Plant collection and aqueous extraction A botanist, Prof. Fahd Al-Zuaiber, at the Department of Biology, Faculty of Science, University of Tabuk, authenticated the fresh, healthy leaves of P. harmala collected at the Red Sea coast within the NEOM sector, Sharma, Saudi Arabia (28.035975, 35.227097). The collection of P. harmala plant materials was performed according to institutional, national, and international guidelines. Our collection methodology follows best practices for sustainable harvesting to ensure no long- term impact on the local ecosystem. Moreover, the collected plant are not rare or endangered plants, rather they are common plants available in Sharma, Saudi Arabia. The vocher specimen no UT/PH/2024/Tabuk/KSA was deposited in the herbarium of the Entomology and Toxicology Laboratory, University of Tabuk, Saudi Arabia. The leaves were thoroughly washed with distilled water, shade-dried for 10–12 days at room temperature, and gently ground with a mechanical grinder. For aqueous extraction, 10 g of leaf powder was boiled in 100 mL of distilled water for 30 min at 70 °C. The mixture was cooled, filtered through filter paper (Whatman No.1), and the filtrate was stored at 4 °C for future use as a stabilising and reducing agent in nano-formulation production. Green synthesis of PVA/ZnO@β-CD nanocomposite The P. harmala leaf extract-assisted PVA/ZnO@β-CD nanocomposite was synthesised via a one-pot green method. Briefly, a clear, homogeneous solution was obtained by dissolving 2 g of PVA and 0.5 g of β-CD in 100 mL of distilled water at 80 °C under magnetic stirring. 0.1 M zinc nitrate was added dropwise under constant stirring following the addition of 10 mL of P. harmala aqueous extract. The resulting mixture was stirred at 80 °C for 2 h to form a white colloidal suspension of ZnO NPs. The sample was subsequently centrifuged at 10,000 rpm for 15 min. It was thereafter rinsed three times with distilled water for purification. Desiccation: The purified product was desiccated at 60 °C, pulverised, and stored in hermetically sealed containers for subsequent examination. Characterisation of nanocomposite The produced nanocomposite was analysed utilising multiple analytical techniques to confirm its structure, morphology, and physicochemical properties. UV–Visible spectroscopy (Shimadzu UV-2600) was used to study optical properties from 200 to 800 nm. FTIR spectroscopy (Bruker Alpha II, 4000–400 cm⁻¹) identified functional groups present. X-ray diffraction over a 2θ range of 20°–80° determined crystalline phases and average crystallite size using the Debye–Scherrer equation. Surface morphology was characterised by FE-SEM (JEOL JSM-7610 F) following gold coating, and HR-TEM (JEOL JEM-2100) provided detailed information on particle size, shape, and lattice fringes. SAED patterns confirmed crystallinity. Hydrodynamic diameter, particle size distribution, and surface charge were determined using DLS (Malvern Zetasizer Nano ZS) to evaluate colloidal stability, and zeta potential was measured. Anticancer activity Cell culture The human breast cancer cell line MDA-MB-231 was obtained from the Riyadh Regional Laboratory, Ministry of Health, Riyadh, Saudi Arabia, and cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic solution. The cells were grown at 37 °C in a humidified CO₂ incubator maintained at 5% CO₂. MTT cytotoxicity assay Cytotoxicity of the PVA/ZnO@β-CD nanocomposite mediated by the leaf extract of P. harmala on breast cancer cells was evaluated using MTT assays. The density of 1 × 10⁴ cells was grown in a 96-well plate and incubated for 24 h. Various concentrations (0.78–100 µg/mL) of the nanocomposite were incubated for 24 h, 48 h, and 72 h, followed by the addition of MTT solution (4 h of incubation), and the formazan crystals were dissolved in DMSO. Cell-treated cells versus untreated control wells were measured for absorbance at 570 nm, and the IC₅₀ value was determined. Antioxidant enzyme assays (SOD, CAT, and GSH) Cells were harvested by trypsinisation and then lysed with RIPA buffer after treated with the PVA/ZnO@β-CD nanocomposite. The supernatant was collected following centrifugation of the lysate at 12,000 rpm for 10 min at 4 °C. The enzyme activities of SOD, CAT, and GSH were determined using commercial biochemical kits according to the manufacturer’s instructions. Protein normalisation was calculated according to the Bradford method. Intracellular ROS measurement by DCFDA staining Intracellular ROS production was assessed using DCF-DA staining. After incubation with the nanocomposite for 24 h, 48 h, and 72 h, the cells were washed twice with PBS and then stained with 10 µM DCFDA at 37 °C in the dark for 30 min. After excess dye was washed with PBS, the cells were observed under a fluorescence microscope (FITC filter). The intensity of green fluorescence indicated the levels of ROS generated in cells. Apoptosis analysis by AO/EtBr dual staining Apoptotic morphological changes were examined using AO/EtBr staining. Both nanocomposite-treated and control cells were washed twice with PBS and stained with an equal mixture of AO (100 µg/mL) and EtBr. After a 5 min incubation at room temperature, excess dye was removed, and the cells were immediately observed under a fluorescent microscope. Live cells appeared green with intact nuclei; early apoptotic cells showed bright green fluorescence with condensed chromatin; late apoptotic cells exhibited orange to red fluorescence; and necrotic cells appeared deep red. Nuclear morphology assessment by DAPI staining Cells treated with nanocomposite were fixed using 4% paraformaldehyde for 15 min, washed with PBS, and stained with 1 µg/mL DAPI for 10 min in the dark. After removing excess stain, fluorescence microscopy with a DAPI filter was used to examine the cells. Apoptotic cells exhibited characteristic nuclear changes, including chromatin condensation and fragmentation, indicative of apoptosis. mRNA expression analysis by qRT-PCR Quantitative real-time PCR (qRT-PCR) was used to evaluate the relative expression levels of Bax, Bcl-2, Caspase-3, and Cytochrome c, with GAPDH as the reference gene. Total RNA was isolated from control and treated cells using QIAzol® Lysis Reagent according to the manufacturer’s protocol, and residual genomic DNA was removed by DNase I treatment. The RNA’s purity and concentration were assessed using a NanoDrop™ spectrophotometer. For cDNA synthesis, 500 ng of total RNA was reverse transcribed using the QuantiTect® Reverse Transcription Kit, which includes a gDNA wipeout step to eliminate genomic DNA contamination. Quantitative PCR amplification was performed using the QuantiNova™ SYBR® Green PCR Kit in a 20 µL reaction volume, including 10 µL of SYBR® Green Master Mix, 0.4 µL of each forward and reverse primer (Table 1), 2 µL of cDNA, and nuclease-free water. The reactions were performed on a QuantStudio™ 5 Real-Time PCR System with the following cycling parameters: initial activation at 95 °C for 2 min, followed by 40 cycles of denaturation at 95 °C for 15 s and concurrent annealing/extension at 60 °C for 30 s. The relative expression of target mRNA was assessed using the 2−ΔΔCt method. Table 1Primer sequenceGeneForward primer sequenceReverse primer sequenceBaxGCGAGTGTCTCAAGCGCATCCCAGTTGAAGTTGCCGTCAGAABcl-2ATGTGTGTGGAGAGCGTCAAC CGCATCCCAGCCTCCGTTATCCaspase-3CAGAACTGGACTGTGGCATTGGCTTGTCGGCATACTGTTTCACytochrome cTCACAAAGATGGTGAGTGCCAGGCAAAAGCACCATTCCCAAGAPDHAGAGCACAAGAGGAAGAGAGAGACAGCACAGGGTACTTTATTGATGGT Table 1Primer sequenceGeneForward primer sequenceReverse primer sequenceBaxGCGAGTGTCTCAAGCGCATCCCAGTTGAAGTTGCCGTCAGAABcl-2ATGTGTGTGGAGAGCGTCAAC CGCATCCCAGCCTCCGTTATCCaspase-3CAGAACTGGACTGTGGCATTGGCTTGTCGGCATACTGTTTCACytochrome cTCACAAAGATGGTGAGTGCCAGGCAAAAGCACCATTCCCAAGAPDHAGAGCACAAGAGGAAGAGAGAGACAGCACAGGGTACTTTATTGATGGT Primer sequence Antimicrobial activity Agar well diffusion method The microbial strains were obtained from Riyadh Regional Laboratory, Ministry of Health, Riyadh, Saudi Arabia. The antibacterial efficacy of the nanocomposite was evaluated employing the agar well diffusion technique. Sterile Mueller-Hinton agar cultures for bacteria and Sabouraud dextrose agar cultures for fungi were inoculated with standardised microbiological suspensions aligned with the 0.5 McFarland standard. Aseptically prepared wells with a diameter of 6 mm were filled with the PVA/ZnO@β-CD nanocomposite at concentrations of 20, 40, 80, and 160 µg/mL. Antibiotics, specifically ampicillin for bacterial infections and fluconazole for fungal infections, functioned as positive controls. Plates were incubated at 37 °C for 24 h for bacteria and at 28 °C for 48 h for fungi. The zones of inhibition surrounding the wells were quantified to assess antibacterial effectiveness. Minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) The MIC and MBC/MFC of the PVA/ZnO@β-CD nanocomposite were determined using the broth microdilution method according to standard guidelines. Briefly, serial twofold dilutions of the PVA/ZnO@β-CD nanocomposite (20–160 µg/mL) were prepared in sterile nutrient broth (for bacteria) or Sabouraud dextrose broth (for fungi) in 96-well microtiter plates. Standardised microbial inocula (1 × 10⁶ CFU/mL) were added to each well and incubated at 37 °C for 24 h for bacteria and at 28–30 °C for 48 h for fungi. The MIC was defined as the lowest concentration at which no visible growth was observed. To determine MBC/MFC, aliquots from wells showing no visible growth were sub-cultured onto agar plates and incubated under the respective conditions; the lowest concentration that did not yield colonies was recorded as the MBC/MFC. Statistical analysis All biological experiments were performed in triplicate (n = 3), and results are expressed as mean ± standard deviation (SD). Each experiment was conducted on different days using independently prepared samples to ensure reproducibility. Statistical significance among groups was evaluated using one-way analysis of variance (ANOVA), followed by Tukey’s post hoc test, with p < 0.05 considered statistically significant. Result and discussion Physicochemical characterisation of PVA/ZnO@β-CD nanocomposite Optical and structural properties The optical and structural properties of the P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite were analysed using UV–Visible spectroscopy and FTIR spectroscopy to confirm the formation and stabilisation of ZnO NPs within the polymeric framework. As shown in Fig. 1a, the UV–vis absorption spectrum of the nanocomposite exhibited a distinct peak at 354.34 nm, corresponding to the intrinsic band-gap transition of ZnO NPs (O 2p → Zn 3d). This characteristic absorption spectrum confirms successful ZnO synthesis within the PVA/β-CD matrix. The slight shift of the absorption peak relative to bulk ZnO (≈ 370 nm) indicates quantum confinement, confirming the nanometric scale of the synthesised particles. This blue shift is a common characteristic of nanoscale ZnO particles, in which the excitonic absorption band shifts to shorter wavelengths as particle size decreases below the exciton Bohr radius [28]. The interactions between ZnO, β-CDs, and the PVA matrix likely influence this shift by altering the local dielectric environment. The presence of P. harmala phytochemicals during synthesis acts as a natural reducing and capping agent, preventing agglomeration and promoting uniform particle nucleation. Additionally, the broad absorption tail extending toward longer wavelengths suggests the presence of minor surface plasmon resonance and residual organic compounds from the plant extract, thereby reinforcing the green synthesis route. Hadap et al. (2025) reported that the enhanced absorption observed in the 350–375 nm range indicates successful ZnO incorporation [29]. Moreover, the inclusion of β-CD can introduce additional structured spectral features indicative of strong host–guest interactions and improved dispersion of ZnO NPs within the matrix. The FTIR spectrum (Fig. 1b) displays characteristic peaks at 3298.27, 2335.79, 1602.84, 1352.10, 1016.48, 713.59, and 617.14 cm⁻¹. A broad absorption band observed at 3298.27 cm⁻¹ corresponds to –OH stretching vibrations, indicating extensive hydrogen bonding between PVA, β-CD, surface hydroxyl groups of ZnO, and phytochemicals derived from P. harmala. The presence of this characteristic –OH band is consistent with earlier reports on PVA-based systems, in which strong hydrogen-bonded networks dominate this spectral region [30]. Distinct peaks at 1602.84 cm⁻¹ and 1352.10 cm⁻¹ are assigned to C = C, C = O, and C–H/C–N stretching vibrations, which can be attributed to aromatic rings and alkaloid constituents present in the P. harmala extract as well as structural features of β-CD. The absorption band at 1016.48 cm⁻¹ corresponds to C–O–C and C–O stretching vibrations, confirming the presence of the polymeric backbone of PVA and β-CD within the nanocomposite matrix [31]. Importantly, the sharp absorption peaks detected at 713.59 cm⁻¹ and 617.14 cm⁻¹ are characteristic of Zn–O stretching vibrations, providing direct evidence for the successful incorporation of ZnO nanoparticles into the hybrid nanocomposite. Similar Zn–O related vibrational features and their interaction with polymer functional groups have been reported in PVA-based hybrid nanocomposites, supporting the present observations [32]. Overall, the FTIR results validate the effective integration of ZnO and phytochemical components within the PVA/β-CD matrix through strong intermolecular interactions. Fig. 1a UV-Visible spectrum, b FTIR spectrum and c XRD spectrum of PVA/ZnO@β-CD nanocomposite a UV-Visible spectrum, b FTIR spectrum and c XRD spectrum of PVA/ZnO@β-CD nanocomposite Figure 1c shows the XRD pattern of the P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite. The diffractogram exhibits distinct peaks at 2θ values around 31.8°, 34.4°, 36.3°, 47.5°, 56.6°, 62.8°, 66.3°, 67.9°, and 69.1°, which correspond to the (100), (002), (101), (102), (110), (103), (112), and (202) crystal planes of ZnO, respectively. These diffraction peaks are well indexed to the hexagonal wurtzite structure of ZnO (JCPDS # 36-1451), confirming the successful formation of crystalline ZnO NPs within the polymeric network. Yadav et al. (2021) reported similar results, with ZnO-β-CD exhibiting high crystallinity corresponding to the characteristic diffraction peaks of ZnO (JCPDS #36-1451) [33]. The broad, less intense peaks observed in the 15–30° region, highlighted in the violet-shaded area, are attributed to the semi-crystalline nature of PVA and to the presence of β-CD. The slight peak broadening and minor shifts indicate nanoscale crystallinity and strong intermolecular interactions among ZnO NPs, β-CD, and PVA chains, which are facilitated by phytochemicals in the P. harmala extract. The average crystallite size, estimated from the prominent (101) peak using the Debye–Scherrer equation, suggests the formation of ZnO nanocrystals in the nanometer range. Morphological properties and elemental distribution The FE-SEM micrographs (Fig. 2a) showing a heterogeneous, compact, and porous surface with uniformly distributed, quasi-spherical to irregular ZnO NPs embedded within the PVA/β-CD matrix are consistent with those of typical polymeric nanocomposites [34]. Although the overall distribution is uniform, the observed small agglomerates often result from strong intermolecular hydrogen bonding and surface-energy interactions between polymer chains and nanoparticles, as noted in similar studies of chitosan films with green-synthesised ZnO/CuO nanocomposites. The porous texture, especially at higher magnifications, is a favourable characteristic for biomedical applications, enhancing surface area and reactivity [35]. The HR-TEM images (Fig. 2b) further confirm well-dispersed ZnO NPs with spherical to hexagonal morphologies and an average size of 15–25 nm. This size range is typical for green-synthesised ZnO nanoparticles [36]. The absence of significant clustering and the clear lattice fringes corresponding to the hexagonal wurtzite ZnO structure validate the stabilising effects of β-CD and the phytochemical constituents of P. harmala. This is supported by other HR-TEM studies showing well-dispersed and capped zinc nanoparticles within polymer networks [37]. The SAED pattern, with its distinct concentric rings, further corroborates the polycrystalline nature of the ZnO nanoparticles. The uniform dispersion achieved by P. harmala phytochemicals underscores their effectiveness as natural reducing and capping agents, thereby minimising aggregation and ensuring structural stability, a hallmark of successful green synthesis [36]. The EDX mapping definitively confirms the presence of zinc, oxygen (O), and carbon (C) as the major constituent elements (Fig. 2c). The high carbon content is expected from the PVA-β-CD polymeric framework, whereas the distinct Zn and O signals confirm the successful incorporation of crystalline ZnO nanoparticles. The homogeneous elemental distribution across the nanocomposite surface signifies efficient integration and strong interfacial interaction between the ZnO NPs and the biopolymeric matrix. This is consistent with findings from other green-synthesised ZnO/polymer nanocomposites, in which elemental mapping confirmed the homogeneous distribution of Zn, C, and O [34, 38]. Chakraborty et al. similarly reported high carbon content in green-synthesised ZnO/chitosan nanocomposites, along with other elements [39]. Fig. 2a FE-SEM image, b HR-TEM and SAED image and c elemental mapping of PVA/ZnO@β-CD nanocomposite a FE-SEM image, b HR-TEM and SAED image and c elemental mapping of PVA/ZnO@β-CD nanocomposite Colloidal behaviour and surface charge stability The DLS measurement (Fig. 3a), showing an average hydrodynamic particle size of 299.4 nm, indicates the formation of nanosized particles with a moderate degree of aggregation. This larger hydrodynamic diameter compared to TEM observations (15–25 nm) is a well-established phenomenon, attributed to the solvation layer and the surrounding polymeric network in an aqueous medium [40]. Such differences are commonly observed in nanocomposites due to the hydration shell and particle-particle interactions in suspension [35]. Studies have reported similar hydrodynamic sizes for polymer-loaded nanocomposites, such as hydrolysed starch/chitosan nanocomposites loaded with ciprofloxacin, with an average hydrodynamic diameter of approximately 291 nm. Fig. 3a DLS b zeta potential of PVA/ZnO@β-CD nanocomposite a DLS b zeta potential of PVA/ZnO@β-CD nanocomposite The observed zeta potential of − 33.62 mV is a significant finding, confirming excellent colloidal stability (Fig. 3b). Zeta potential values beyond ± 30 mV typically indicate strong electrosta [41]. This robust negative surface charge originates from the numerous hydroxyl and carboxyl groups present in PVA, β-CD, and the adsorbed phytochemicals from P. harmala extract on the nanoparticle surface [40]. The combination of nanoscale particle size and a high negative zeta potential indicates that the biosynthesised PVA/ZnO@β-CD nanocomposite is highly stable and well-dispersed, making it a promising candidate for various biomedical and environmental applications. This stability is crucial for maintaining the integrity and efficacy of the nanocomposite in biological systems [42]. Evaluation of anticancer potential Cytotoxic response and cell viability assessment Figure 4 illustrates the MTT assay results of the P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite against the MDA-MB-231 human breast cancer cell line. Cytotoxicity was assessed across a concentration range of 0–100 µg/mL, with a pronounced dose- and time-dependent decrease in cell viability. The nanocomposite exhibited IC₅₀ values of 24.45 µg/mL at 24 h, 20.83 µg/mL at 48 h, and 12.74 µg/mL at 72 h, indicating a time-dependent increase in antiproliferative efficacy against aggressive triple-negative breast cancer cells. The reduction in cell viability by the PVA/ZnO@β-CD nanocomposite is attributed to a combination of mechanisms, including oxidative stress induced by ZnO nanoparticles, mitochondrial dysfunction, and apoptosis. Additionally, bioactive phytochemicals from P. harmala contribute to this cytotoxic effect, enhancing the overall anticancer potential of the nanocomposite [43, 44]. The polymers in the matrix enhanced nanoparticle dispersion and cellular uptake, thereby improving the overall cytotoxic efficiency [45]. Haghparasti et al. (2018) demonstrated that green-synthesised silver montmorillonite (Ag@Mt) nanocomposites made using white tea leaf extract caused a dose-dependent decrease in viability of MOLT-4 leukaemia cells [46]. Similarly, Motafeghi et al. (2023) found that silver–graphene nanocomposites synthesised with Melissa officinalis ethanolic extract exhibited significant cytotoxicity against MCF-7 breast cancer cells [47]. To evaluate the biosafety of the nanocomposite toward non-cancerous cells, the cytotoxic effect of the P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite was also assessed in normal human mammary epithelial cells (HMECs) using the MTT assay (Figure S1). HMECs were exposed to the nanocomposite over the same concentration range (0–100 µg/mL) and incubation periods (24, 48, and 72 h). In contrast to the marked antiproliferative activity observed in MDA-MB-231 cells, HMECs exhibited high cell viability across all tested concentrations and time points, with only negligible reductions even at the highest dose. Notably, the IC₅₀ value for HMECs was not reached within the tested concentration range (> 100 µg/mL), indicating minimal cytotoxicity toward normal breast epithelial cells. These findings demonstrate the selective anticancer activity of the PVA/ZnO@β-CD nanocomposite, highlighting its preferential toxicity toward malignant breast cancer cells while maintaining good biocompatibility with normal mammary cells. Similarly, other studies on ZnO nanoparticles have demonstrated selective toxicity toward cancerous T cells relative to normal cells, and minimal cytotoxic effects on umbilical endothelial HUVECs at cytotoxic doses of ZnO-NPs used against breast cancer cells [48, 49]. Fig. 4MTT assay showing the effect of P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite on cell viability at different concentrations and exposure times. Cells were treated with various concentrations of NER-βCD-NPs (ranging from 0 to 100 µg/mL) for durations of 24, 48, and 72 h. The MTT assay data, presented as the mean ± standard deviation from three separate experiments, showed a clear dose- and time-dependent reduction in cell viability relative to the untreated control group MTT assay showing the effect of P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite on cell viability at different concentrations and exposure times. Cells were treated with various concentrations of NER-βCD-NPs (ranging from 0 to 100 µg/mL) for durations of 24, 48, and 72 h. The MTT assay data, presented as the mean ± standard deviation from three separate experiments, showed a clear dose- and time-dependent reduction in cell viability relative to the untreated control group Induction of oxidative stress and ROS generation Nanocomposites can act as pro-oxidants in cancer cells, producing excessive ROS, upsetting the redox balance, and causing oxidative stress. This high ROS level destroys cellular components such as DNA, proteins, and lipids, ultimately leading to apoptosis. Thus, the pro-oxidant activity of nanocomposites is critical to their anticancer efficacy [50]. The P. harmala leaf extract-mediated PVA/ZnO@β-CD nanocomposite was studied in MDA-MB-231 to determine its oxidative stress-related cytotoxic processes. Figure 5a depicts the activity of the antioxidant enzymes SOD, CAT, and GSH after nanocomposite treatment (24, 48, and 72 h). Compared with the untreated control, a time-dependent reduction in antioxidant enzyme levels was observed. This marked depletion indicates enhanced ROS generation and disruption of cellular redox balance, signifying oxidative stress–mediated apoptosis. Similarly, Premnath et al. (2025) reported that ZrO₂/Rutin/rGO nanocomposites significantly reduced the activities of antioxidant enzymes, including SOD, CAT, GPx, and GSH, in MDA-MB-231 cells, indicating enhanced oxidative stress–mediated cytotoxicity [51]. Ahamed et al. (2021) reported that SnO₂-doped ZnO/reduced graphene oxide nanocomposites exhibit pro-oxidant activity in the MCF-7 breast cancer cell line by significantly reducing the activities of antioxidant enzymes such as SOD, CAT, and GPx [50]. Fig. 5Antioxidant enzyme activity and intracellular ROS generation in MDA-MB-231 cells treated with P. harmala leaf extract-mediated PVA/ZnO@β-CD nanocomposite. a The activity of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) was measured after 24 h, 48 h, and 72 h of treatment. Data are presented as mean ± SD (n = 3). Significant changes compared to the control are given as p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). b Intracellular ROS generation was visualised using DCFDA fluorescent staining. The intensity of green fluorescence increased with exposure time (24, 48, and 72 h), indicating elevated ROS production in treated cells relative to controls. Scale bar = 100 μm Antioxidant enzyme activity and intracellular ROS generation in MDA-MB-231 cells treated with P. harmala leaf extract-mediated PVA/ZnO@β-CD nanocomposite. a The activity of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) was measured after 24 h, 48 h, and 72 h of treatment. Data are presented as mean ± SD (n = 3). Significant changes compared to the control are given as p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). b Intracellular ROS generation was visualised using DCFDA fluorescent staining. The intensity of green fluorescence increased with exposure time (24, 48, and 72 h), indicating elevated ROS production in treated cells relative to controls. Scale bar = 100 μm Figure 5b further confirms this using DCFDA fluorescence staining, in which intracellular ROS levels increased progressively with increasing nanocomposite treatment duration (24, 48, and 72 h). The treated cells exhibited strong green fluorescence relative to the control, indicating significant ROS accumulation. The elevated ROS generation is attributed primarily to ZnO NPs, which are known to generate ROS upon cellular internalisation, and is further enhanced by bioactive compounds from the plant extract [52]. Additionally, the polymer matrix improves nanoparticle dispersion, stability, and cellular uptake, thereby sustaining intracellular ROS generation [53]. Similarly, Joe et al. (2024) synthesised triphenylphosphonium-functionalized gold nanorod/zinc oxide (CTPP-GNR@ZnO) core–shell nanocomposites, which significantly increased intracellular ROS generation in colon cancer cell lines, thereby enhancing oxidative stress and cancer cell death [54]. This redox imbalance triggers mitochondrial dysfunction and apoptotic signalling, underscoring the nanocomposite’s potent anticancer efficacy and its promise as a green-engineered nanotherapeutic agent for breast cancer management. Morphological evidence of apoptosis The apoptotic potential of P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite was evaluated in MDA-MB-231 using AO/EtBr and DAPI staining. AO/EtBr dual staining distinguishes viable (green fluorescence) and apoptotic or necrotic (orange/red fluorescence) cells, while DAPI binds to DNA, revealing nuclear condensation and fragmentation associated with apoptosis. As shown in Fig. 6a and b, untreated control cells exhibited intact membranes and uniformly stained nuclei, confirming healthy morphology. Upon treatment with the nanocomposite (24, 48, and 72 h), a time-dependent increase in apoptotic features was observed. At 24 h, cells exhibited early apoptotic features, including chromatin condensation, membrane blebbing, and mild nuclear shrinkage. At 48 h, numerous cells showed late apoptotic characteristics, including fragmented nuclei and intense orange/red or bright blue fluorescence. At 48 h, it caused extensive nuclear fragmentation, apoptotic body formation, and strong fluorescence signals, confirming potent apoptotic induction. These results indicate that the PVA/ZnO@β-CD nanocomposite induces apoptosis in a time-dependent manner. Bharathi et al. (2023) demonstrated that a biosynthesised kaempferol-chitosan/silver (Kf-CS/Ag) nanocomposite induced apoptosis and nuclear morphological changes in MDA-MB-231 cells, as confirmed by AO/EtBr and DAPI staining [55]. Similarly, Shanmugam et al. (2025) reported that a nanocomposite composed of ZIF-8 and ZrO₂, loaded with curcumin and encapsulated within an alginate polymer matrix, induced apoptosis in MDA-MB-231 cells in a time-dependent fashion [56]. The observed cytotoxicity is most likely due to the combined impact of P. harmala bioactive alkaloids and the ROS-generating capabilities of ZnO NPs, which together alter mitochondrial function and induce apoptotic cascades. The consistency of the AO/EtBr and DAPI staining data supports the hypothesis that nanocomposite-mediated cell death occurs primarily by apoptosis rather than necrosis, thereby validating the findings of the MTT cytotoxicity assay. Fig. 6Fluorescence microscopic analysis of apoptosis and nuclear morphology in cells treated with P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite. a AO/EtBr dual staining of cells showing time-dependent induction of apoptosis following treatment with PVA/ZnO@β-CD nanocomposite for 24, 48, and 72 h compared with untreated control. Viable cells fluoresce green, whereas early- and late-apoptotic cells exhibit yellow/orange to red fluorescence. b Quantitative analysis of apoptotic cells (%) by AO/EtBr staining, demonstrating a significant, time-dependent increase in apoptosis following nanocomposite treatment. c DAPI staining showing nuclear morphological changes, including chromatin condensation and nuclear fragmentation, in treated cells at 24, 48, and 72 h relative to control. d Quantification of nuclear alterations (%) from DAPI-stained cells, indicating a progressive increase in nuclear damage with prolonged exposure. Data are presented as mean ± SD (n = 3). Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001 vs. control). Scale bar = 100 μm Fluorescence microscopic analysis of apoptosis and nuclear morphology in cells treated with P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite. a AO/EtBr dual staining of cells showing time-dependent induction of apoptosis following treatment with PVA/ZnO@β-CD nanocomposite for 24, 48, and 72 h compared with untreated control. Viable cells fluoresce green, whereas early- and late-apoptotic cells exhibit yellow/orange to red fluorescence. b Quantitative analysis of apoptotic cells (%) by AO/EtBr staining, demonstrating a significant, time-dependent increase in apoptosis following nanocomposite treatment. c DAPI staining showing nuclear morphological changes, including chromatin condensation and nuclear fragmentation, in treated cells at 24, 48, and 72 h relative to control. d Quantification of nuclear alterations (%) from DAPI-stained cells, indicating a progressive increase in nuclear damage with prolonged exposure. Data are presented as mean ± SD (n = 3). Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001 vs. control). Scale bar = 100 μm Molecular insights into apoptotic gene regulation Transcriptional expression of key apoptotic regulatory genes was evaluated in MDA-MB-231 cells treated with a P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite using RT-PCR. The nanocomposite treatment caused significant, time-dependent changes in gene expression compared to untreated controls. After 24 h, there was a slight increase in the pro-apoptotic genes Bax, Caspase-3, and Cytochrome c and a small decrease in the anti-apoptotic gene Bcl-2. Prolonged treatment at 48 h and 72 h led to a marked upregulation of Bax, Caspase-3, and Cytochrome c and significant downregulation of Bcl-2, indicating enhanced apoptosis signalling over time. This pattern reflects the regulatory roles of these genes in promoting and inhibiting apoptosis, confirming the nanocomposite’s apoptotic effect. The PVA/ZnO@β-CD nanocomposite exhibited the strongest apoptotic gene modulation, reflected by an elevated Bax/Bcl-2 ratio, indicating activation of the intrinsic (mitochondrial) apoptotic pathway. These findings align with the reports of Motafeghi et al. (2023) and Mehraban et al. (2023), who demonstrated that comparable nanocomposites modulate the Bax/Bcl-2 ratio in breast cancer cells [47, 57] (Fig. 7). Fig. 7qRT-PCR study of apoptosis-related gene expression in MDA-MB-231 cells treated with a P. harmala leaf extract-mediated PVA/ZnO@β-CD nanocomposite. The relative mRNA expression levels of Bax, Bcl-2, cytochrome c, and caspase-3 were measured at 24 h, 48 h, and 72 h after therapy. The pro-apoptotic genes (Bax, cytochrome c, and caspase-3) were markedly elevated in a time-dependent manner, whereas the anti-apoptotic gene (Bcl-2) was downregulated relative to control. Data are presented as mean ± SD (n = 3). Statistical significance relative to control: p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) qRT-PCR study of apoptosis-related gene expression in MDA-MB-231 cells treated with a P. harmala leaf extract-mediated PVA/ZnO@β-CD nanocomposite. The relative mRNA expression levels of Bax, Bcl-2, cytochrome c, and caspase-3 were measured at 24 h, 48 h, and 72 h after therapy. The pro-apoptotic genes (Bax, cytochrome c, and caspase-3) were markedly elevated in a time-dependent manner, whereas the anti-apoptotic gene (Bcl-2) was downregulated relative to control. Data are presented as mean ± SD (n = 3). Statistical significance relative to control: p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) Upregulation of Bax levels compromises the integrity of the mitochondrial outer membrane, thereby releasing cytochrome c into the cytosol. This release activates caspase-3, an essential executioner enzyme responsible for DNA fragmentation and formation of apoptotic bodies [58, 59]. Similarly, Buskaran et al. (2020) observed that protocatechuic acid added to folate-coated functionalized graphene oxide (GOP-PCA-FA) nanocomposites enhanced caspase and cytochrome c expression in HepG2 cells [60]. Concurrent downregulation of the anti-apoptotic protein Bcl-2 favours apoptosis over necrosis, supporting programmed cell death rather than uncontrolled cell death [61]. These observations corroborate the morphological and staining-based apoptosis findings (AO/EtBr and DAPI assays), confirming that the cytotoxicity induced by the P. harmala–mediated PVA/ZnO@β-CD nanocomposite in MDA-MB-231 cells occurs through a mitochondria-dependent apoptotic pathway. The interaction between P. harmala phytochemicals and ZnO NPs likely augments ROS generation and mitochondrial dysfunction, thereby triggering downstream apoptotic signalling cascades. Assessment of antimicrobial efficacy The antibacterial and antifungal activities of the synthesised P. harmala leaf extract–mediated PVA/ZnO@β-CD nanocomposite were evaluated against bacteria and fungi, using the agar well diffusion method (Fig. 8). The nanocomposite exhibited broad-spectrum antimicrobial activity in a dose-dependent manner, as evidenced by larger inhibition zones at higher concentrations (20–160 µL). Among the Gram-positive bacteria, S. pneumoniae showed the highest sensitivity, with a maximum inhibition zone of 21 ± 0.89 mm at 160 µg/mL, followed by S. aureus (20 ± 0.99 mm) and B. subtilis (18 ± 0.62 mm). The increased susceptibility of S. pneumoniae may be attributed to its thinner peptidoglycan layer, which facilitates more efficient penetration and interaction of ZnO NPs with the bacterial membrane, thereby inducing oxidative stress and cell lysis. Similarly, the nanocomposite demonstrated significant antibacterial activity against Gram-negative bacteria, including K. pneumoniae (21 ± 0.37 mm), S. typhi (20 ± 0.55 mm), and E. coli (18 ± 0.87 mm) at the highest tested concentration. Although Gram-negative bacteria possess an outer lipopolysaccharide layer that typically offers resistance, the enhanced activity observed can be ascribed to the small particle size and surface reactivity of ZnO NPs, which facilitate ROS generation and membrane disruption. The antifungal efficacy of the nanocomposite was also evident, as shown by substantial zones of inhibition against A. candidus (19 ± 1.41 mm), C. albicans (19±0.085 mm), and C. auris (16 ± 0.94 mm). Overall, the PVA/ZnO@β-CD nanocomposite exhibited broad-spectrum antimicrobial activity, demonstrating its potential as an effective biocidal material. Dawwam et al. (2022) reported that cellulose nanocrystal/ZnO bio-nanocomposites exhibited strong antibacterial activity and effectively suppressed virulence-related genes in food-borne pathogens [62]. Similarly, Selim et al. (2025) reported that green-synthesised MgO–ZnO nanocomposites exhibited broad-spectrum antimicrobial activity, highlighting the role of phytochemical-mediated stabilisation and combined effects [63]. The enhanced antibacterial performance of ZnO/PVA nanocomposites, attributed to improved nanoparticle dispersion and sustained antimicrobial action, was reported by Abebe et al. (2021) [64]. Moreover, Almutairi et al. (2023) reported that β-CD based nanocomposites significantly improved antibacterial efficacy by increasing nanoparticle stability and facilitating stronger interactions with microbial membranes [65]. Al Abboud et al. (2024) reported that the bi-metallic nanocomposite ZnO@AuNPs shows strong antimicrobial and antioxidant activity [66]. Fig. 8Antibacterial and antifungal effects of the PVA/ZnO@β-CD nanocomposite against various pathogenic microbes using the agar well diffusion assay. The tested microorganisms include Gram-positive (S. aureus, S. pneumoniae, B. subtilis), Gram-negative (E. coli, K. pneumoniae, S. typhi), and fungal (A. candidus, C. auris, C. albicans). Different concentrations of the nanocomposite (20, 40, 80, and 160 µL) showed a dose-dependent inhibition of microbial growth Antibacterial and antifungal effects of the PVA/ZnO@β-CD nanocomposite against various pathogenic microbes using the agar well diffusion assay. The tested microorganisms include Gram-positive (S. aureus, S. pneumoniae, B. subtilis), Gram-negative (E. coli, K. pneumoniae, S. typhi), and fungal (A. candidus, C. auris, C. albicans). Different concentrations of the nanocomposite (20, 40, 80, and 160 µL) showed a dose-dependent inhibition of microbial growth The MIC and MBC/MFC of the PVA/ZnO@β-CD nanocomposite were evaluated against selected bacterial and fungal strains, and the results are presented in Table 2. S. aureus, B. subtilis, E. coli, S. typhi, and C. albicans showed visible growth at 20 µg/mL but were completely inhibited at 40 µg/mL, indicating an MIC of 40 µg/mL and an MBC/MFC of 80 µg/mL. S. pneumoniae and K. pneumoniae were more susceptible, exhibiting complete growth inhibition at 20 µg/mL with corresponding MBC values at 40 µg/mL. In contrast, fungal strains (A) candidus and C. auris exhibited higher resistance, with growth observed up to 40 µg/mL and complete inhibition at 80 µg/mL, yielding MIC and MFC values of 80 and 160 µg/mL, respectively. Overall, the findings demonstrate broad-spectrum antimicrobial activity of the PVA/ZnO@β-CD nanocomposite, with greater efficacy against bacterial pathogens than against fungal species. Similarly, Yassin et al. (2023) studied PVA/CMC/ZnO blends. They reported antibacterial activity against (B) subtilis and E. coli, as well as antifungal activity against (C) albicans, albeit with varying degrees of potency across microbial species [67]. Similarly, other studies on PVA/chitosan/ZnO nanocomposites have demonstrated significant antibacterial activity against both Gram-positive and Gram-negative bacteria [68]. This study is limited to in vitro evaluations; therefore, confirmation of apoptotic mechanisms at the protein expression level and validation through in vivo studies are required. In addition, a comparative analysis of the individual components (P. harmala extract, ZnO NPs, PVA, and β-CD) is necessary to establish true synergistic effects. Future studies should focus on these aspects to enhance the nanocomposite’s translational potential. Table 2MIC and MBC/MFC of PVA/ZnO@β-CD nanocomposite against selected bacterial and fungal pathogensMicroorganism20 µg/mL40 µg/mL80 µg/mL160 µg/mLMIC (µg/mL)MBC/MFC (µg/mL) S. aureus +–––4080 S. pneumoniae ––––2040 B. subtilis +–––4080 E. coli +–––4080 K. pneumoniae ––––2040 Salmonella typhi +–––4080 A. candidus ++––80160 C. albicans +–––4080 C. auris ++––80160(+) indicates visible microbial growth and ,. (–) indicates complete inhibition of growth Table 2MIC and MBC/MFC of PVA/ZnO@β-CD nanocomposite against selected bacterial and fungal pathogensMicroorganism20 µg/mL40 µg/mL80 µg/mL160 µg/mLMIC (µg/mL)MBC/MFC (µg/mL) S. aureus +–––4080 S. pneumoniae ––––2040 B. subtilis +–––4080 E. coli +–––4080 K. pneumoniae ––––2040 Salmonella typhi +–––4080 A. candidus ++––80160 C. albicans +–––4080 C. auris ++––80160(+) indicates visible microbial growth and ,. (–) indicates complete inhibition of growth MIC and MBC/MFC of PVA/ZnO@β-CD nanocomposite against selected bacterial and fungal pathogens (+) indicates visible microbial growth and ,. (–) indicates complete inhibition of growth Conclusion In conclusion, a stable and biocompatible PVA/ZnO@β-CD nanocomposite was successfully synthesised using P. harmala leaf extract via an eco-friendly green approach. Comprehensive physicochemical analyses confirmed the crystalline nature, nanoscale dimensions, uniform dispersion, and strong interfacial interactions within the polymeric matrix. The nanocomposite exhibited excellent colloidal stability and a porous morphology, attributes that are favourable for biomedical and antimicrobial applications. Biologically, it demonstrated selective and time-dependent cytotoxicity against aggressive MDA-MB-231 breast cancer cells while sparing normal mammary epithelial cells, highlighting its therapeutic selectivity. Mechanistic investigations established that the anticancer activity is predominantly mediated through ROS overproduction, antioxidant depletion, mitochondrial dysfunction, and activation of the intrinsic apoptotic pathway. In parallel, the nanocomposite showed broad-spectrum antibacterial and antifungal efficacy, underscoring its multifunctional bioactivity. Overall, this study establishes the PVA/ZnO@β-CD nanocomposite as a promising green nanoplatform for integrated cancer therapy and antimicrobial applications. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2